These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20859667)

  • 1. Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
    Kumánovics A; Perkins SL; Gilbert H; Cessna MH; Augustine NH; Hill HR
    J Clin Immunol; 2010 Nov; 30(6):886-93. PubMed ID: 20859667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid molecular analysis of the STAT3 gene in Job syndrome of hyper-IgE and recurrent infectious diseases.
    Kumánovics A; Wittwer CT; Pryor RJ; Augustine NH; Leppert MF; Carey JC; Ochs HD; Wedgwood RJ; Faville RJ; Quie PG; Hill HR
    J Mol Diagn; 2010 Mar; 12(2):213-9. PubMed ID: 20093388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
    Alcántara-Montiel JC; Vega-Torres BI
    Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
    Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
    J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
    Xie L; Hu X; Li Y; Zhang W; Chen L
    Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
    Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
    Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyper IgE syndromes: clinical and molecular characteristics.
    Al-Shaikhly T; Ochs HD
    Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyper-IgE syndrome update.
    Sowerwine KJ; Holland SM; Freeman AF
    Ann N Y Acad Sci; 2012 Feb; 1250():25-32. PubMed ID: 22268731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell-specific STAT3 deficiency: Insight into the molecular basis of autosomal-dominant hyper-IgE syndrome.
    Kane A; Lau A; Brink R; Tangye SG; Deenick EK
    J Allergy Clin Immunol; 2016 Nov; 138(5):1455-1458.e3. PubMed ID: 27423495
    [No Abstract]   [Full Text] [Related]  

  • 10. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome.
    Vinh DC; Sugui JA; Hsu AP; Freeman AF; Holland SM
    J Allergy Clin Immunol; 2010 Jun; 125(6):1389-90. PubMed ID: 20392475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 mutations in the hyper-IgE syndrome.
    Holland SM; DeLeo FR; Elloumi HZ; Hsu AP; Uzel G; Brodsky N; Freeman AF; Demidowich A; Davis J; Turner ML; Anderson VL; Darnell DN; Welch PA; Kuhns DB; Frucht DM; Malech HL; Gallin JI; Kobayashi SD; Whitney AR; Voyich JM; Musser JM; Woellner C; Schäffer AA; Puck JM; Grimbacher B
    N Engl J Med; 2007 Oct; 357(16):1608-19. PubMed ID: 17881745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.
    Ives ML; Ma CS; Palendira U; Chan A; Bustamante J; Boisson-Dupuis S; Arkwright PD; Engelhard D; Averbuch D; Magdorf K; Roesler J; Peake J; Wong M; Adelstein S; Choo S; Smart JM; French MA; Fulcher DA; Cook MC; Picard C; Durandy A; Tsumura M; Kobayashi M; Uzel G; Casanova JL; Tangye SG; Deenick EK
    J Allergy Clin Immunol; 2013 Aug; 132(2):400-11.e9. PubMed ID: 23830147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India.
    Saikia B; Suri D; Goel S; Rawat A; Minz RW; Gupta A; Sharma S; Ohara O; Imai K; Nonoyama S; Sehgal S; Singh S
    Asian Pac J Allergy Immunol; 2014 Dec; 32(4):321-7. PubMed ID: 25543043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
    Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
    Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
    Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
    J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral aneurysm in a 12-year-old boy with a STAT3 mutation (hyper-IgE syndrome).
    Kim Y; Nard JA; Saad A; Casselman J; Wessell KR; Toller-Artis E; Tcheurekdijan H; Hostoffer RW
    Ann Allergy Asthma Immunol; 2015 May; 114(5):430-1. PubMed ID: 25814298
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
    Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
    J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyper-IgE Syndromes and the Lung.
    Freeman AF; Olivier KN
    Clin Chest Med; 2016 Sep; 37(3):557-67. PubMed ID: 27514600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).
    Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX
    Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel STAT3 mutation associated with hyper immunoglobulin E syndrome with a paucity of connective tissue signs.
    Yoshida Y; Nagamori T; Takahashi H; Ishibazawa E; Shimada S; Kawai T; Azuma H
    Pediatr Int; 2021 May; 63(5):510-515. PubMed ID: 32920916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.